Document Detail


Vitamin C and smoke inhalation injury.
MedLine Citation:
PMID:  19060764     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A second potential therapeutic option for the parenchymal damage caused by inhalation injury is systemic administration of intravenous agents. The unique nature of the effects of the burn and smoke on lung physiology and immunology create new opportunities for systemic treatments targeting specific aspects of the response to injury. In addition, systemic therapies could be either isolated or combined with inhalation therapies to achieve optimal clinical response. The two articles in this section of the compendium address different, yet promising, systemic therapies: antithrombin and vitamin C.
Authors:
Steven E Wolf
Related Documents :
19005324 - Velopharyngeal insufficiency: current concepts in diagnosis and management.
942314 - Myotonia congenita with painful muscle contractions.
2069544 - Bentonite as therapy for lantana camara poisoning of cattle.
9256534 - Recent progress in treating patients with cleft palate.
21681084 - An online self-help cbt intervention for chronic lower back pain.
1758814 - The incidence of cancer pain and improvement of pain management in japan.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of burn care & research : official publication of the American Burn Association     Volume:  30     ISSN:  1559-047X     ISO Abbreviation:  -     Publication Date:    2009 Jan-Feb
Date Detail:
Created Date:  2009-01-12     Completed Date:  2009-03-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101262774     Medline TA:  J Burn Care Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  184-6     Citation Subset:  IM    
Affiliation:
Department of Surgery, University of Texas Health Science Centre, San Antonio, Texas 78286-3900, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antioxidants / therapeutic use*
Ascorbic Acid / therapeutic use*
Humans
Smoke Inhalation Injury / drug therapy*
Chemical
Reg. No./Substance:
0/Antioxidants; 50-81-7/Ascorbic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development of a clothing iron safety device.
Next Document:  Oscillation after inhalation: high frequency oscillatory ventilation in burn patients with the acute...